Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Cerebral cavernous malformations (CCMs) are prevalent brain vascular abnormalities and a primary cause of hemorrhagic stroke.
• CCMs are genetically linked to mutations in KRIT1, CCM2, and PDCD10 genes.

Purpose of the Study:

• To investigate the distinct cellular and developmental roles of KRIT1, CCM2, and PDCD10 in CCM pathogenesis.
• To compare the in vivo and in vitro functions of PDCD10 with those of CCM2 and KRIT1.

Main Methods:

• Comparative analysis of developmental, cell biological, and signaling phenotypes in mouse models lacking Ccm2, Krit1, or Pdcd10.
• In vivo and in vitro studies examining the role of PDCD10 in endothelial cell lumen formation.
• Genotype-specific comparison of murine CCM phenotypes with human surgical specimens.

Main Results:

• Loss of Pdcd10 results in distinct phenotypes compared to the absence of Ccm2 and Krit1.
• PDCD10 interacts with germinal center kinase III (GCKIII) kinases to promote endothelial lumen formation.
• Loss of heterozygosity for Pdcd10 or Ccm2 in mice recapitulates key clinical features of human CCMs.

Conclusions:

• CCMs may represent a common tissue outcome of divergent molecular pathways.
• Therapeutic strategies for CCMs could be more effective when tailored to specific genetic mutations rather than a uniform clinical approach.